Featured

Canada NewsWire HAMILTON , ON and BOSTON , April 1, 2021 /CNW/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prntac{TEXT-ALIGN: CENTER}   Canada NewsWire Topical FS2 shows statistically significant improvement versus the market leader VANCOUVER, BC,Jan. 22, 2021/CNW/ –